Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Appointment

Aslan licences promising cancer drug from Bristol-Myers Squibb

November 7, 2011 Research and Development, Sales and Marketing Aslan, BMS, Cancer

Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …
News

Xarelto gains lucrative new licence from FDA

November 7, 2011 Sales and Marketing

The FDA has approved Bayer/J&J’s Xarelto once-daily pill for stroke prevention in patients with an abnormal heart rhythm. The US …
News

Ranbaxy to collaborate with Teva on generic Lipitor in US?

November 7, 2011 Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …
News

Steve Hobbs joins Apodi senior management team

November 4, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …
Appointment

Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board

November 4, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA

GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …
Appointment

Cancer drugs should not receive special funding – MS Society

November 4, 2011 Sales and Marketing ABPI, Cancer Drugs Fund, MS Society, NICE

 
News

GSK pays $3 billion to settle US marketing probe

November 3, 2011 Sales and Marketing GSK, compliance, federal investigation

GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …
News

Synergy Vision hires Caroline Loder and Natalie Ferguson

November 3, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision

Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …
Appointment

Teva sees modest growth as US sales fall

November 3, 2011 Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …
News

Doctors decry cost-cutting in HIV treatment

November 2, 2011 Sales and Marketing HIV, NHS, Reyataz

Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …
News

Richard Daniell appointed as managing director of Teva UK

November 2, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical

Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …
Appointment

Sanofi to become world’s biggest drug maker

November 2, 2011 Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10

Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts.  Pfizer’s nine-year …
News

Prevnar and Lyrica lift Pfizer results

November 1, 2011 Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …
News

Obama takes action to curb medicine shortages

November 1, 2011 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs

US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026